ProfileGDS2971 / 3.2.2.18
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 15% 8% 31% 31% 49% 71% 86% 49% 70% 57% 43% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.66170815
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.9733128
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.23709231
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.28698931
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-0.0015071849
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.29076571
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.876886
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.011834549
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.3476370
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)0.18030857
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.071321443
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-1.964916